搜索临床试验以:SHR-1701,法米替尼
总计4064个结果
-
Antengene (Hangzhou) Biologics Co., Ltd.招聘中
-
CorrectSequence Therapeutics Co., LtdFirst Affiliated Hospital of Guangxi Medical University邀请报名
-
Tvardi Therapeutics, IncorporatedM.D. Anderson Cancer Center主动,不招人
-
Verve Therapeutics, Inc.主动,不招人
-
Aldagen终止
-
Lingli DongShenzhen Pregene Biopharma Co., Ltd.招聘中
-
Weill Medical College of Cornell UniversityTG Therapeutics, Inc.终止
-
Hangzhou Cancer HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Sun Yat-sen UniversityChongqing University Cancer Hospital; Jiangxi Provincial Cancer Hospital; Shenzhen People's Hospital 和其他合作者招聘中
-
Jiangsu HengRui Medicine Co., Ltd.招聘中先前接受过曲妥珠单抗和紫杉烷治疗的 HER2 阳性、不可切除和/或转移性乳腺癌受试者中国
-
University of MichiganAgency for Healthcare Research and Quality (AHRQ)完全的
-
Novartis Pharmaceuticals完全的
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Scioderm, Inc.Amicus Therapeutics完全的大疱性表皮松解症意大利, 西班牙, 塞尔维亚, 美国, 澳大利亚, 荷兰, 奥地利, 德国, 以色列, 立陶宛, 法国, 英国, 波兰
-
Eledon Pharmaceuticals终止
-
H. Lee Moffitt Cancer Center and Research InstituteJames and Esther King Biomedical Research Program完全的
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)终止
-
University of Colorado, DenverTvardi Therapeutics, Incorporated招聘中
-
Sentien Biotechnologies, Inc.主动,不招人
-
BioMarin Pharmaceutical完全的